EIA
TMDX icon

Emerald Investment Advisers’s Transmedics TMDX Stock Holding History

Emerald Investment Advisers’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.02M Buy
30,456
+5,414
+22% +$458K 0.13% 185
2026
Q1 		$2.49M Buy
+25,042
New +$3.27M 0.22% 144

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Emerald Investment Advisers's TMDX Position: Q2 2026 in Review

Emerald Investment Advisers increased its Transmedics (TMDX) stake by 22% in Q2 2026, buying an estimated $458K and bringing the position to 30,456 shares worth $2.02M. The position accounts for 0.13% of the portfolio, ranked #185.

Emerald Investment Advisers first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.49M in Q1 2026. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Emerald Investment Advisers held 30,456 shares of Transmedics worth $2.02M as of Q2 2026.
  • Emerald Investment Advisers bought 5,414 Transmedics shares in Q2 2026, an estimated $458K.
  • Transmedics made up 0.13% of Emerald Investment Advisers's portfolio in Q2 2026, its #185 holding.
  • Emerald Investment Advisers first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • Emerald Investment Advisers's Transmedics position peaked at $2.49M in Q1 2026.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Emerald Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.